Detalhe da pesquisa
1.
Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative.
Ann Surg Oncol;
31(5): 3314-3324, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38310181
2.
Neighborhood-Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy.
Ann Surg Oncol;
30(12): 7840-7847, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37620532
3.
Influence of insurance status on the postoperative outcomes of cytoreductive surgery and HIPEC.
J Surg Oncol;
127(4): 706-715, 2023 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36468401
4.
Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a prospective clinical trial and comparative analysis.
Surg Endosc;
37(7): 5644-5651, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36477643
5.
Co-Localization of Gastrointestinal Stromal Tumors (GIST) and Peritoneal Mesothelioma: A Case Series.
Ann Surg Oncol;
29(12): 7542-7548, 2022 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35849291
6.
A Multi-institutional Study of Peritoneal Recurrence Following Resection of Low-grade Appendiceal Mucinous Neoplasms.
Ann Surg Oncol;
28(8): 4685-4694, 2021 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33415564
7.
Impact of Perioperative Blood Transfusions on Outcomes After Hyperthermic Intraperitoneal Chemotherapy: A Propensity-Matched Analysis.
Ann Surg Oncol;
28(8): 4499-4507, 2021 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33507449
8.
A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPEC.
J Surg Oncol;
123(1): 187-195, 2021 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33002202
9.
Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal Metastases.
Ann Surg Oncol;
27(9): 3259-3267, 2020 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32767050
10.
CRS/HIPEC with Major Organ Resection in Peritoneal Mesothelioma Does not Impact Major Complications or Overall Survival: A Retrospective Cohort Study of the US HIPEC Collaborative.
Ann Surg Oncol;
27(13): 4996-5004, 2020 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33073341
11.
Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective Study.
Ann Surg Oncol;
27(13): 4883-4891, 2020 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32318945
12.
Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative.
Ann Surg Oncol;
27(13): 4980-4995, 2020 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32696303
13.
Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter?
Ann Surg Oncol;
27(3): 783-792, 2020 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31659645
14.
Predictors of Non-home Discharge after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
J Surg Res;
255: 475-485, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32622162
15.
Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: An opportunity for enhanced recovery pathways.
J Surg Oncol;
122(5): 980-985, 2020 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32627199
16.
The impact of HIPEC vs. EPIC for the treatment of mucinous appendiceal carcinoma: a study from the US HIPEC collaborative.
Int J Hyperthermia;
37(1): 1182-1188, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33040617
17.
Obstruction-Free Survival Following Operative Intervention for Malignant Bowel Obstruction in Appendiceal Cancer.
Ann Surg Oncol;
26(11): 3611-3617, 2019 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31190209
18.
Incidence, Risk Factors, and Prevention Strategies for Venous Thromboembolism after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Ann Surg Oncol;
26(7): 2276-2284, 2019 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31065960
19.
Does Primary Tumor Side Matter in Patients with Metastatic Colon Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy?
Ann Surg Oncol;
26(5): 1421-1427, 2019 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30815802
20.
Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study.
Ann Surg Oncol;
26(7): 2234-2240, 2019 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31016486